Literature DB >> 9610417

Fragile-X syndrome and myotonic dystrophy: parallels and paradoxes.

S J Tapscott1, T R Klesert, R J Widrow, R Stöger, C D Laird.   

Abstract

Fragile-X syndrome and myotonic dystrophy are caused by triplet repeat expansions embedded in CpG islands in the transcribed non-coding regions of the FMR1 and the DMPK genes, respectively. Although initial reports emphasized differences in the mechanisms by which the expanded triplet repeats caused these diseases, results published in the past year highlight remarkable parallels in the likely molecular etiologies. At both loci, expansion is associated with altered chromatin, aberrant methylation, and suppressed expression of the adjacent FMR1 and DMAHP genes, implicating epigenetic mediation of these genetic diseases.

Entities:  

Mesh:

Year:  1998        PMID: 9610417     DOI: 10.1016/s0959-437x(98)80148-2

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  7 in total

1.  Tandem repeat deletion in the alpha C protein of group B streptococcus is recA independent.

Authors:  K M Puopolo; S K Hollingshead; V J Carey; L C Madoff
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  Myotonic dystrophy: the role of RNA CUG triplet repeats.

Authors:  L T Timchenko
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

3.  The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome.

Authors:  Daman Kumari; Karen Usdin
Journal:  Hum Mol Genet       Date:  2010-09-14       Impact factor: 6.150

Review 4.  Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia.

Authors:  Elisabetta Soragni; Chunping Xu; Heather L Plasterer; Vincent Jacques; James R Rusche; Joel M Gottesfeld
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

Review 5.  Small molecules affecting transcription in Friedreich ataxia.

Authors:  Joel M Gottesfeld
Journal:  Pharmacol Ther       Date:  2007-08-09       Impact factor: 12.310

Review 6.  Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy.

Authors:  Daniele Marmolino; Fabio Acquaviva
Journal:  Cerebellum       Date:  2009-01-23       Impact factor: 3.847

Review 7.  The many hues of plant heterochromatin.

Authors:  J L Bennetzen
Journal:  Genome Biol       Date:  2000-06-09       Impact factor: 13.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.